Cargando…

421 Activity of Tigecycline and Comparators Against Lower Respiratory Tract (LRT) Isolates of Enterobacteriaceae from North America and Europe: 2009-2013

Detalles Bibliográficos
Autores principales:	Hoban, Daryl, Bouchillon, Samuel, Hackel, Meredith, Johnson, Brian, Badal, Robert, Johnson, Jack, Hawser, Stephen, Leister-Tebbe, Heidi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781516/ http://dx.doi.org/10.1093/ofid/ofu052.287

Ejemplares similares

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013
por: Johnson, Brian, et al.
Publicado: (2014)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013
por: Hackel, Meredith, et al.
Publicado: (2014)

412 In vitro Activity of Key Antimicrobial Agents Against Bacterial Isolates From Intra-abdominal (IAI) and Skin and Wound (SW) Infections: Europe 2004-2013
por: Hoban, Daryl, et al.
Publicado: (2014)

424 Characterization and Profiling of Multi-Drug Resistant (MDR) Enterobacteriaceae From Latin America
por: Renteria, Martha, et al.
Publicado: (2014)

Fluoroquinolone Resistance Among Gram-Negative Urinary Tract Pathogens: Global Smart Program Results, 2009-2010
por: Bouchillon, Sam, et al.
Publicado: (2012)

254 In Vitro Activity of Ceftazidime in Combination with Avibactam vs 1825 Pseudomonas aeruginosa Clinical Isolates Obtained from across Canada as Part of the CANWARD Study, 2009-2013
por: Walkty, Andrew, et al.
Publicado: (2014)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

422 Antimicrobial Susceptibility Profiles of Key Blood and Respiratory Bacterial Isolates from Africa and the Middle East
por: Renteria, Martha, et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

297 Trends in Staphylococcus aureus (SA) Isolation in 28 US Hospitals, 2009-2013
por: Diekema, Daniel J., et al.
Publicado: (2014)

363 Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013
por: Adler, Amos, et al.
Publicado: (2014)

1712 An Integrated Surveillance for Antimicrobial-Resistance in Salmonella from Clinical and Retail Meat Sources — Pennsylvania, 2009-2013
por: Mikanatha, Nkuchia, et al.
Publicado: (2014)

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011
por: Morrissey, Ian, et al.
Publicado: (2013)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

1741 Emergence of Shigellosis in Males ≥13 Years — Philadelphia, 2008–2013
por: Finn, Lauren, et al.
Publicado: (2014)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

729 Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013)
por: Sader, Helio S., et al.
Publicado: (2014)

250 Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants
por: Castanheira, Mariana, et al.
Publicado: (2014)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

Tigecycline Susceptibility Trends Among Pathogens Isolated from Complicated Skin and Soft-Tissue Infections in North and Latin America: 2012–2016
por: Hoban, Daryl, et al.
Publicado: (2017)

1141 2013-2014 Resurgence of 2009 Influenza A (H1N1) Infection among Adults: Has the Epidemiology and Clinical Severity of Disease Changed?
por: Arnold, John, et al.
Publicado: (2014)

364 Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization
por: Lewis, Jessica, et al.
Publicado: (2014)

253 Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City
por: Abdallah, Marie, et al.
Publicado: (2014)

249 Activity of Plazomicin Against Contemporary Isolates of Enterobacteriaceae from New York City
por: Olafisoye, Olawole, et al.
Publicado: (2014)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

423 Comparison of pediatric community-acquired, healthcare-associated, and hospital-acquired infections caused by extended-spectrum cephalosporin-resistant Enterobacteriaceae
por: Adler, Amanda, et al.
Publicado: (2014)

1734 Cyclosporiasis 2013: Collaborative Outbreak Investigations
por: Gensheimer, Kathleen, et al.
Publicado: (2014)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

347 Antimicrobial Susceptibility of OXA-48, NDM-1 And VIM-4 Carbapenemase-producing Clinical Isolates of Enterobacteriaceae From Kuwait Government Hospitals
por: Jamal, Wafaa, et al.
Publicado: (2014)

1743 Racial Disparities Among Tuberculosis Deaths in the United States, 1999-2009
por: Chaudhari, Shilpa, et al.
Publicado: (2014)

1738 Estimated Annual Perinatal Hepatitis B Virus Infections, 2000-2009
por: Ko, Stephen, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l8324kqh6im449bi9jjhcc6odf